These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 15535431)

  • 41. Dipeptidyl peptidase IV inhibitors: a promising new therapeutic approach for the management of type 2 diabetes.
    Deacon CF; Holst JJ
    Int J Biochem Cell Biol; 2006; 38(5-6):831-44. PubMed ID: 16242377
    [TBL] [Abstract][Full Text] [Related]  

  • 42. MK-431 (Merck).
    Deacon CF
    Curr Opin Investig Drugs; 2005 Apr; 6(4):419-26. PubMed ID: 15898349
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Synthesis and structure-activity relationships of potent 4-fluoro-2-cyanopyrrolidine dipeptidyl peptidase IV inhibitors.
    Fukushima H; Hiratate A; Takahashi M; Mikami A; Saito-Hori M; Munetomo E; Kitano K; Chonan S; Saito H; Suzuki A; Takaoka Y; Yamamoto K
    Bioorg Med Chem; 2008 Apr; 16(7):4093-106. PubMed ID: 18243000
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Diastereoselective synthesis and configuration-dependent activity of (3-substituted-cycloalkyl)glycine pyrrolidides and thiazolidides as dipeptidyl peptidase IV inhibitors.
    Ashton WT; Dong H; Sisco RM; Doss GA; Leiting B; Patel RA; Wu JK; Marsilio F; Thornberry NA; Weber AE
    Bioorg Med Chem Lett; 2004 Feb; 14(4):859-63. PubMed ID: 15012982
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Aminomethylpyridines as DPP-IV inhibitors.
    Peters JU; Weber S; Kritter S; Weiss P; Wallier A; Zimmerli D; Boehringer M; Steger M; Loeffler BM
    Bioorg Med Chem Lett; 2004 Jul; 14(13):3579-80. PubMed ID: 15177478
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pralnacasan (vertex pharmaceuticals).
    Siegmund B; Zeitz M
    IDrugs; 2003 Feb; 6(2):154-8. PubMed ID: 12789619
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Natural products for Alzheimer's disease therapy: basic and application.
    Xiao J; Tundis R
    J Pharm Pharmacol; 2013 Dec; 65(12):1679-80. PubMed ID: 24236979
    [No Abstract]   [Full Text] [Related]  

  • 48. [The clinical pharmacokinetics of kemantane].
    Boĭko SS; Zherdev VP; Kisliak NA
    Farmakol Toksikol; 1991; 54(1):57-9. PubMed ID: 1860503
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Oxiracetam].
    Gava R; Schifano F
    G Clin Med; 1989 Jan; 70(1):69-72. PubMed ID: 2668093
    [No Abstract]   [Full Text] [Related]  

  • 50. [Interspecific differences in kemantan pharmacokinetics].
    Boĭko SS; Zherdev VP; Kisliak NA; Piatin BM; Klimova NV; Glan PV; Dvorianinov AA
    Eksp Klin Farmakol; 1994; 57(6):48-50. PubMed ID: 7756963
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [The pharmacokinetics of adamantanes].
    Sergeeva SA; Krasnykh LM
    Eksp Klin Farmakol; 1994; 57(3):69-74. PubMed ID: 8049625
    [No Abstract]   [Full Text] [Related]  

  • 52. [Therapeutic use of Tavegil].
    Grejniec A; Tytman B
    Wiad Lek; 1970 May; 23(10):827-8. PubMed ID: 5425470
    [No Abstract]   [Full Text] [Related]  

  • 53. PharmaForum Novartis.
    Oncol Res Treat; 2019; 42(4):226-227. PubMed ID: 30965349
    [No Abstract]   [Full Text] [Related]  

  • 54. Exubera(®) (inhaled insulin): an evidence-based review of its effectiveness in the management of diabetes.
    Profit L
    Core Evid; 2005; 1(2):89-101. PubMed ID: 22500147
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Molecular docking and 3D-QSAR studies on beta-phenylalanine derivatives as dipeptidyl peptidase IV inhibitors.
    Jiang YK
    J Mol Model; 2010 Jul; 16(7):1239-49. PubMed ID: 20069322
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The role of incretins in glucose homeostasis and diabetes treatment.
    Kim W; Egan JM
    Pharmacol Rev; 2008 Dec; 60(4):470-512. PubMed ID: 19074620
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Incretin-based therapies in type 2 diabetes mellitus.
    Chia CW; Egan JM
    J Clin Endocrinol Metab; 2008 Oct; 93(10):3703-16. PubMed ID: 18628530
    [TBL] [Abstract][Full Text] [Related]  

  • 58. LAF-237 (Novartis).
    Barlocco D
    Curr Opin Investig Drugs; 2004 Oct; 5(10):1094-100. PubMed ID: 15535431
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dipeptidyl peptidase IV inhibitors for the treatment of diabetes.
    Weber AE
    J Med Chem; 2004 Aug; 47(17):4135-41. PubMed ID: 15293982
    [No Abstract]   [Full Text] [Related]  

  • 60. Dipeptidyl peptidase-4 inhibitors: clinical data and clinical implications.
    Ahrén B
    Diabetes Care; 2007 Jun; 30(6):1344-50. PubMed ID: 17337494
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.